Fri, Sep 19, 3:40 PM, Zacks
Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog
Bristol-Myers (BMY) Yervoy gained Canadian approval for treating adults newly diagnosed with advanced melanoma.
Wed, Sep 17, 1:00 PM, Zacks
Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog
FDA approvals, a positive FDA panel outcome and positive phase II data were the key highlights in the biotech sector last week.